drug design platform technology, peptide platform technologies and nanotechnology - they have established a product pipeline with first/best in class potential.

Through development and commercialization partnerships they have already delivered three medicines to the market (two COPD bronchodilators and an emergency contraceptive), which generate significant and stable revenue streams that enable further growth.